AT1 5.00% 1.9¢ atomo diagnostics limited

AT1 FY21 - General Discussion + FA, page-1497

  1. 5,536 Posts.
    lightbulb Created with Sketch. 578
    this is the problem with Atomo (or maybe impatient investors): everything is forthcoming

    pair that with the opaqueness of the finances (a missing couple of $millon invoices that did not turn into cash receipts and no communication of the bumpiness of revenue)... and you have one big black hole of factual info; I joke, but if somebody calls Joe Hockey, we may get some info; Atomo itself is abysmal at letting owner know that is going on; let us take AccessBio for example

    - a 2 mill units order of which they provided 260k; Atomo know WHEN the rest will be supplied (q3 or q4) and/or they know if perhaps it will turn in into pay part of take or pay; and what that entails; some people close to Atomo know what is going on; yet they refuse to tell the retail investors

    And re the AccessBio, John was simply a 'smart arse' when asked in an interview re the financials behind it... he went all coy, but did say it can be figured out... well, John, if it can be figured out then why the freakin h3ll dont you just say; it would be like having no revenue and cash flow financials in the half yearly or yearly and say 'well, you can figure it out by looking at the last few quarterlies'
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.